Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-06-001566
Filing Date
2006-06-16
Accepted
2006-06-16 15:10:51
Documents
1
Period of Report
2006-06-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1964
  Complete submission text file 0001127602-06-001566.txt   3880
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O GENAISSANCE PHARMACEUTICALS INC FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address 2037731450
KLEIN JOSEPH III (Reporting) CIK: 0001206369 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15190 | Film No.: 06910071